Trial Profile
Clinical Pharmacology study for AS-3201 in renal impairment subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranirestat (Primary)
- Indications Renal impairment
- Focus Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 08 Jun 2016 New trial record